Whole-Exome Sequencing in 22 Young Ischemic Stroke Patients With Familial Clustering of Stroke.


Journal

Stroke
ISSN: 1524-4628
Titre abrégé: Stroke
Pays: United States
ID NLM: 0235266

Informations de publication

Date de publication:
04 2020
Historique:
pubmed: 17 3 2020
medline: 17 9 2020
entrez: 17 3 2020
Statut: ppublish

Résumé

Backgrounds and Purpose- Although new methods for genetic analyses are rapidly evolving, there are currently knowledge gaps in how to detect Mendelian forms of stroke. Methods- We performed whole-exome sequencing in 22 probands, under 56 years at their first ischemic stroke episode, from multi-incident stroke families. With the use of a comprehensive stroke-gene panel, we searched for variants in stroke-related genes. The probands' clinical stroke subtype was related to clinical characteristics previously associated with pathogenic variants in these genes. Relatives were genotyped in 7 families to evaluate stroke-gene variants of unknown significance. In 2 larger families with embolic stroke of unknown source, whole-exome sequencing was performed in additional members to examine the possibility of identifying new stroke genes. Results- Six of 22 probands carried pathogenic or possibly pathogenic variants in genes reported to be associated with their stroke subtype. A known pathogenic variant in

Identifiants

pubmed: 32172663
doi: 10.1161/STROKEAHA.119.027474
pmc: PMC7584402
mid: NIHMS1560210
doi:

Types de publication

Clinical Trial Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1056-1063

Subventions

Organisme : NIDDK NIH HHS
ID : P30 DK072488
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS100178
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS105150
Pays : United States

Commentaires et corrections

Type : CommentIn
Type : ErratumIn

Références

Eur J Neurol. 2016 Feb;23(2):401-7
pubmed: 26499090
Neurology. 2015 Mar 3;84(9):918-26
pubmed: 25653287
Genome Res. 2010 Sep;20(9):1297-303
pubmed: 20644199
Nature. 2016 Aug 17;536(7616):285-91
pubmed: 27535533
Eur J Hum Genet. 2017 Nov;25(11):1253-1260
pubmed: 28832569
Stroke. 2004 Jan;35(1):212-27
pubmed: 14684773
Biochem Biophys Res Commun. 2005 May 27;331(1):363-9
pubmed: 15845401
Nature. 2009 Oct 8;461(7265):747-53
pubmed: 19812666
Blood. 2008 May 15;111(10):4922-9
pubmed: 18250227
Genet Med. 2015 Nov;17(11):843-53
pubmed: 25719457
Nature. 2013 May 9;497(7448):211-6
pubmed: 23636330
Nat Genet. 2010 Dec;42(12):1131-4
pubmed: 21057504
Blood. 2016 Sep 8;128(10):1418-23
pubmed: 27389715
Blood. 2016 Nov 3;128(18):2266-2270
pubmed: 27647865
N Engl J Med. 2013 Dec 26;369(26):2504-14
pubmed: 24369075
Nature. 1996 Oct 24;383(6602):707-10
pubmed: 8878478
Nucleic Acids Res. 2016 Jan 4;44(D1):D862-8
pubmed: 26582918
Am J Hum Genet. 2007 Jul;81(1):87-103
pubmed: 17564966
N Engl J Med. 2012 Mar 8;366(10):967-9
pubmed: 22397670
Nucleic Acids Res. 2010 Sep;38(16):e164
pubmed: 20601685
Cerebrovasc Dis. 2005;20(5):381-7
pubmed: 16205056
Am J Hum Genet. 2012 Jan 13;90(1):91-101
pubmed: 22209247
Eur Stroke J. 2017 Jun;2(2):116-125
pubmed: 31008307
Lancet Neurol. 2014 Apr;13(4):429-38
pubmed: 24646875
Stroke. 2007 Nov;38(11):2979-84
pubmed: 17901381
Genet Med. 2015 May;17(5):405-24
pubmed: 25741868
Clin Appl Thromb Hemost. 2018 Dec;24(9_suppl):42S-47S
pubmed: 30428703
Proc Natl Acad Sci U S A. 1996 Mar 19;93(6):2307-11
pubmed: 8637868
Eur J Hum Genet. 2019 Feb;27(2):317-324
pubmed: 30356112
J Recept Signal Transduct Res. 2017 Jun;37(3):290-296
pubmed: 27807998
Ann Transl Med. 2014 Dec;2(12):125
pubmed: 25568878
Nature. 2015 Oct 1;526(7571):68-74
pubmed: 26432245
Neuroepidemiology. 2014;42(3):161-8
pubmed: 24556909
Int J Epidemiol. 2017 Aug 1;46(4):1223-1229
pubmed: 28338862
Neurology. 2017 Oct 24;89(17):1829-1839
pubmed: 28954878
Stroke. 2015 Mar;46(3):615-9
pubmed: 25613305
Blood Adv. 2017 Jun 29;1(16):1224-1237
pubmed: 29296762
Srp Arh Celok Lek. 1998 Mar-Apr;126(3-4):111-8
pubmed: 9863366
Matrix Biol. 2017 Jan;57-58:29-44
pubmed: 27794444

Auteurs

Andreea Ilinca (A)

From the Department of Clinical Sciences Lund, Neurology (A.I., A.P., A.L.), Lund University, Sweden.
Department of Neurology and Rehabilitation Medicine, Neurology, Skåne University Hospital, Sweden (A.L., A.P., A.L.).

Nicolas Martinez-Majander (N)

Department of Neurology, Helsinki University Hospital, Finland (N.M.-M., J.P.).

Sofie Samuelsson (S)

Department of Clinical Genetics and Pathology (S.S., P.P.), Lund University, Sweden.

Paul Piccinelli (P)

Department of Clinical Genetics and Pathology (S.S., P.P.), Lund University, Sweden.

Katarina Truvé (K)

Bioinformatics Core Facility, Sahlgrenska Academy at University of Gothenburg, Sweden (K.T.).

John Cole (J)

Department of Neurology, Veterans Affairs Maryland Health Care System (J.C., S.K.), University of Maryland School of Medicine, Baltimore.

Steven Kittner (S)

Department of Neurology, Veterans Affairs Maryland Health Care System (J.C., S.K.), University of Maryland School of Medicine, Baltimore.
Department of Neurology (S.K.), University of Maryland School of Medicine, Baltimore.

Maria Soller (M)

Department of Clinical Genetics, Karolinska University Hospital, Solna, Sweden (M.S.).

Ulf Kristoffersson (U)

Division of Clinical Genetics, Laboratory Medicine (U.K.), Lund University, Sweden.

Turgut Tatlisumak (T)

Department of Clinical Neuroscience, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Sweden (T.T.).

Andreas Puschmann (A)

From the Department of Clinical Sciences Lund, Neurology (A.I., A.P., A.L.), Lund University, Sweden.
Department of Neurology and Rehabilitation Medicine, Neurology, Skåne University Hospital, Sweden (A.L., A.P., A.L.).

Jukka Putaala (J)

Department of Neurology, Helsinki University Hospital, Finland (N.M.-M., J.P.).

Arne Lindgren (A)

From the Department of Clinical Sciences Lund, Neurology (A.I., A.P., A.L.), Lund University, Sweden.
Department of Neurology and Rehabilitation Medicine, Neurology, Skåne University Hospital, Sweden (A.L., A.P., A.L.).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH